MedTrace Logo

Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications

NCT06768320 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to treat toddler obesity by improving the toddler nutritional environment. Parents will participate in a free internet nutrition program and may also take obesity medication. These measures may improve the parental nutritional environment and in turn, improve the toddler nutritional environment as well.

Conditions

Interventions

DRUG

Lomaira 8Mg Tablet

8 mg tablet up to three times a day

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Warren C Peters, MD · Loma Linda University (School of Public Health)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2027-01-31
Completion
2027-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06768320 on ClinicalTrials.gov